EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Dividend per Share 2 30 32 32 42 57 29.5 29.5
Rate of return 1.8% 2.42% 1.65% 1.46% 2.5% 1.15% 1.15%
EPS 2 100 36.05 34.83 54.76 61.15 68.52 78.88
Distribution rate 30% 88.8% 91.9% 76.7% 93.2% 43% 37.4%
Reference price 2 1,662.95 1,324.15 1,943.10 2,877.30 2,283.40 2,566.55 2,566.55
Nbr of stocks (in thousands) 1,69,406 1,69,406 1,69,406 1,69,406 1,69,406 1,69,406 -
Announcement Date 16/05/22 17/05/23 17/05/24 13/05/25 13/05/26 - -
1INR in Million2INR
Estimates

Past dividends: GlaxoSmithKline Pharmaceuticals Limited

29/05/2026

Ex-dividend date - 57 INR

09:30 am

Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y)
1.11%1.11%38.63x16.97x -
0.61%0.67%34.02x20.24x11.84x
2.11%2.21%28.36x6.88x6.26x
2.84%2.96%31.72x886.55x7.19x
2.79%2.86%19.93x7.13x4.73x
2.84%2.97%21.85x6.15x5.66x
2.11%2.23%20.2x4.54x4.19x
2.59%2.73%25.61x19.68x6.68x
3.7%3.6%13.52x5.86x5.15x
2.44%2.52%-48.74x8.55x5.83x
Average 2.31% 2.39% 18.51x 98.25x 6.39x
Weighted average by Cap. 2.04% 2.12% 23.71x 118.83x 7.54x
See all sector dividends

Year-on-year evolution of the Yield

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Estimates Revisions

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Annual Profit -